Company Announcements - Guangqi Technology's subsidiary signed a mass production contract for metamaterials worth 1.278 billion yuan with five clients, with delivery expected by June 30, 2026 [1] - Guizhou Moutai's controlling shareholder received a loan commitment letter from Agricultural Bank for a maximum of 2.7 billion yuan to support stock buyback plans, aiming to increase holdings between 3 billion and 3.3 billion yuan within six months [2] - Tianji Co., Ltd. announced a reduction of 3 million shares by its controlling shareholder, decreasing their stake from 18.26% to 17.65% [2] - Baili Tianheng's drug, a dual-target ADC, has been included in the priority review process by the National Medical Products Administration [2] - Aerospace Hongtu signed a strategic cooperation agreement with Pakistan for an internet satellite project valued at 2.9 billion yuan, although it is still a preliminary intention [3] - Huada Jiutian's major shareholder plans to transfer 2.64% of the company's shares through an inquiry transfer [9] Investment & Contracts - Lianchuang Optoelectronics plans to jointly invest in establishing a commercial aerospace operation company with a registered capital of 80 million yuan, holding a 30% stake [11] - Jincong Power's coal power project has been approved with a total investment of 7.518 billion yuan [12] Share Buybacks & Reductions - Yingke Medical adjusted its share buyback price ceiling to 41.88 yuan per share, with a total buyback fund of 80 million to 120 million yuan [14] - Keta Bio's shareholders plan to reduce their holdings by up to 5% of the company's shares [15] Performance & Operations - Muyuan Foods reported a 12.3% year-on-year decrease in August sales revenue from commodity pigs, totaling 11.85 billion yuan [21] - New Hope's August sales revenue from pigs fell by 30.73% year-on-year, amounting to 1.722 billion yuan [21] Contracts & Project Wins - Southeast Network Framework won a bid for an EPC project worth 1.323 billion yuan [24] Other Announcements - Hikvision's chairman proposed a mid-term dividend plan for 2025, distributing 4 yuan per 10 shares, totaling approximately 3.666 billion yuan [28] - Zhizheng Co. received approval from the China Securities Regulatory Commission for a major asset swap [28]

Group 1 - The company, Aipeng Medical (300753.SZ), announced that its subsidiary, Shenzhen Pengrui Brain Science Technology Co., Ltd., has recently obtained the Medical Device Registration Certificate issued by the Guangdong Provincial Drug Administration [1] - The registered products include a portable electroencephalogram (EEG) machine and a portable EEG collector [1]

Core Viewpoint - Aipeng Medical's subsidiary Shenzhen Pengrui Brain Science Technology Co., Ltd. has obtained the Medical Device Registration Certificate from the Guangdong Provincial Drug Administration for its portable EEG machine and portable EEG collector, which are key components of the company's multimodal ADHD behavior training system [1] Group 1 - The products, named UMind Pro and UMind SE, are primarily used for the detection, display, storage, and transmission of brain electrical signals [1] - The innovation provides a clinical application pathway for intelligent behavior therapy management of ADHD (Attention Deficit Hyperactivity Disorder) [1] - This milestone is crucial for the implementation of the company's multimodal ADHD behavior training system in practical scenarios [1]

Core Viewpoint - The company Aipeng Medical has recently obtained a medical device registration certificate for portable EEG machines and portable EEG acquisition devices from the Guangdong Provincial Drug Administration [1] Group 1 - Aipeng Medical's subsidiary, Shenzhen Pengrui Brain Science Technology Co., Ltd., is responsible for the newly registered products [1] - The registered products include portable EEG machines and portable EEG acquisition devices, indicating a focus on innovative medical technology [1]

Core Viewpoint - The company, Aipeng Medical (300753.SZ), has recently obtained the Medical Device Registration Certificate from the Guangdong Provincial Drug Administration for its portable electroencephalogram (EEG) machine and portable EEG collector [1] Group 1 - Aipeng Medical's subsidiary, Shenzhen Pengrui Brain Science Technology Co., Ltd., is responsible for the newly certified medical devices [1] - The certification includes two specific products: a portable EEG machine and a portable EEG collector [1]

Core Viewpoint - The announcement highlights that the company's subsidiary, Shenzhen Pengrui Brain Science Technology Co., Ltd., has obtained medical device registration certificates for portable EEG machines and portable EEG collectors, which are essential components of the company's multimodal ADHD behavior training system [1] Group 1 - The registered products include a portable EEG machine and a portable EEG collector, both with a validity period of 5 years [1] - The registration certificate numbers are 粤械注准20252071190 for the portable EEG machine and 粤械注准20252071188 for the portable EEG collector [1] - The development of these products is expected to positively impact the company's expansion in brain science, neurological disease diagnosis, and cognitive training fields [1]